Candesant Biomedical
Nashville, United States · Founded 2015 · $44.1M raised
- Headquarters
- Nashville, Tennessee
- Employees
- 11–50
- Founded
- 2015
- Business Model
- B2C
- Website
- candesant.com
- Total Funding
- $44.1M
- Last Round
- $35.0M Series BJun 2023
- Rounds
- 2
About
Medical device company developing non-invasive treatments for hyperhidrosis, makers of the FDA-cleared Brella SweatControl Patch.
Summary
Candesant Biomedical is a Biotech company based in Nashville, United States, founded in 2015. It has raised $44.1M in total across 2 rounds, most recently a $35.0M Series B round in Jun 2023. Investors include Polaris Partners, KCK MedTech and Correlation Ventures.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...